nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—Pancytopenia—Bleomycin—skin cancer	0.00365	0.00365	CcSEcCtD
Cefuroxime—Blood bilirubin increased—Docetaxel—skin cancer	0.00363	0.00363	CcSEcCtD
Cefuroxime—Anaphylactic shock—Vemurafenib—skin cancer	0.0036	0.0036	CcSEcCtD
Cefuroxime—Skin disorder—Vemurafenib—skin cancer	0.0035	0.0035	CcSEcCtD
Cefuroxime—Nausea—Vismodegib—skin cancer	0.00347	0.00347	CcSEcCtD
Cefuroxime—Agitation—Imiquimod—skin cancer	0.00346	0.00346	CcSEcCtD
Cefuroxime—Angioedema—Imiquimod—skin cancer	0.00344	0.00344	CcSEcCtD
Cefuroxime—Phosphatase alkaline increased—Docetaxel—skin cancer	0.00343	0.00343	CcSEcCtD
Cefuroxime—Pancytopenia—Dactinomycin—skin cancer	0.0034	0.0034	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.00337	0.00337	CcSEcCtD
Cefuroxime—Neutropenia—Dactinomycin—skin cancer	0.00335	0.00335	CcSEcCtD
Cefuroxime—Stomatitis—Bleomycin—skin cancer	0.00334	0.00334	CcSEcCtD
Cefuroxime—Palpitations—Imiquimod—skin cancer	0.00333	0.00333	CcSEcCtD
Cefuroxime—Colitis—Docetaxel—skin cancer	0.0033	0.0033	CcSEcCtD
Cefuroxime—Irritability—Fluorouracil—skin cancer	0.0033	0.0033	CcSEcCtD
Cefuroxime—Cough—Imiquimod—skin cancer	0.00329	0.00329	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00328	0.00328	CcSEcCtD
Cefuroxime—Candida infection—Docetaxel—skin cancer	0.00328	0.00328	CcSEcCtD
Cefuroxime—Convulsion—Imiquimod—skin cancer	0.00326	0.00326	CcSEcCtD
Cefuroxime—Chest pain—Imiquimod—skin cancer	0.00321	0.00321	CcSEcCtD
Cefuroxime—Arthralgia—Imiquimod—skin cancer	0.00321	0.00321	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00318	0.00318	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00317	0.00317	CcSEcCtD
Cefuroxime—Decreased appetite—Vemurafenib—skin cancer	0.00313	0.00313	CcSEcCtD
Cefuroxime—Bronchitis—Temozolomide—skin cancer	0.00312	0.00312	CcSEcCtD
Cefuroxime—Stomatitis—Dactinomycin—skin cancer	0.00311	0.00311	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00311	0.00311	CcSEcCtD
Cefuroxime—Haemoglobin—Bleomycin—skin cancer	0.00309	0.00309	CcSEcCtD
Cefuroxime—Pancytopenia—Temozolomide—skin cancer	0.00308	0.00308	CcSEcCtD
Cefuroxime—Haemorrhage—Bleomycin—skin cancer	0.00307	0.00307	CcSEcCtD
Cefuroxime—Dysuria—Temozolomide—skin cancer	0.00303	0.00303	CcSEcCtD
Cefuroxime—Neutropenia—Temozolomide—skin cancer	0.00303	0.00303	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Temozolomide—skin cancer	0.00301	0.00301	CcSEcCtD
Cefuroxime—Tachycardia—Imiquimod—skin cancer	0.003	0.003	CcSEcCtD
Cefuroxime—Skin disorder—Imiquimod—skin cancer	0.00299	0.00299	CcSEcCtD
Cefuroxime—Agranulocytosis—Dactinomycin—skin cancer	0.00298	0.00298	CcSEcCtD
Cefuroxime—Hyperhidrosis—Imiquimod—skin cancer	0.00297	0.00297	CcSEcCtD
Cefuroxime—Eosinophilia—Fluorouracil—skin cancer	0.00295	0.00295	CcSEcCtD
Cefuroxime—Anorexia—Imiquimod—skin cancer	0.00293	0.00293	CcSEcCtD
Cefuroxime—Infestation NOS—Temozolomide—skin cancer	0.00289	0.00289	CcSEcCtD
Cefuroxime—Infestation—Temozolomide—skin cancer	0.00289	0.00289	CcSEcCtD
Cefuroxime—Thrombophlebitis—Docetaxel—skin cancer	0.00288	0.00288	CcSEcCtD
Cefuroxime—Hepatitis—Dactinomycin—skin cancer	0.00287	0.00287	CcSEcCtD
Cefuroxime—Blood alkaline phosphatase increased—Docetaxel—skin cancer	0.00287	0.00287	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00286	0.00286	CcSEcCtD
Cefuroxime—Body temperature increased—Vemurafenib—skin cancer	0.00285	0.00285	CcSEcCtD
Cefuroxime—Pancytopenia—Fluorouracil—skin cancer	0.00283	0.00283	CcSEcCtD
Cefuroxime—Stomatitis—Temozolomide—skin cancer	0.00282	0.00282	CcSEcCtD
Cefuroxime—Urinary tract infection—Temozolomide—skin cancer	0.00281	0.00281	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Imiquimod—skin cancer	0.0028	0.0028	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Fluorouracil—skin cancer	0.00277	0.00277	CcSEcCtD
Cefuroxime—Chills—Bleomycin—skin cancer	0.00276	0.00276	CcSEcCtD
Cefuroxime—Dyspnoea—Imiquimod—skin cancer	0.00274	0.00274	CcSEcCtD
Cefuroxime—Somnolence—Imiquimod—skin cancer	0.00273	0.00273	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Temozolomide—skin cancer	0.00273	0.00273	CcSEcCtD
Cefuroxime—Erythema multiforme—Dactinomycin—skin cancer	0.00271	0.00271	CcSEcCtD
Cefuroxime—Sinusitis—Temozolomide—skin cancer	0.00271	0.00271	CcSEcCtD
Cefuroxime—Dyspepsia—Imiquimod—skin cancer	0.00271	0.00271	CcSEcCtD
Cefuroxime—Erythema—Bleomycin—skin cancer	0.00268	0.00268	CcSEcCtD
Cefuroxime—Decreased appetite—Imiquimod—skin cancer	0.00267	0.00267	CcSEcCtD
Cefuroxime—Infestation—Fluorouracil—skin cancer	0.00266	0.00266	CcSEcCtD
Cefuroxime—Infestation NOS—Fluorouracil—skin cancer	0.00266	0.00266	CcSEcCtD
Cefuroxime—Hypersensitivity—Vemurafenib—skin cancer	0.00266	0.00266	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Imiquimod—skin cancer	0.00265	0.00265	CcSEcCtD
Cefuroxime—Pain—Imiquimod—skin cancer	0.00263	0.00263	CcSEcCtD
Cefuroxime—Renal impairment—Docetaxel—skin cancer	0.00262	0.00262	CcSEcCtD
Cefuroxime—Haemoglobin—Temozolomide—skin cancer	0.00261	0.00261	CcSEcCtD
Cefuroxime—Stomatitis—Fluorouracil—skin cancer	0.00259	0.00259	CcSEcCtD
Cefuroxime—Haemorrhage—Temozolomide—skin cancer	0.00259	0.00259	CcSEcCtD
Cefuroxime—Hepatitis—Temozolomide—skin cancer	0.00259	0.00259	CcSEcCtD
Cefuroxime—Urinary tract infection—Fluorouracil—skin cancer	0.00259	0.00259	CcSEcCtD
Cefuroxime—Chills—Dactinomycin—skin cancer	0.00257	0.00257	CcSEcCtD
Cefuroxime—Urinary tract disorder—Temozolomide—skin cancer	0.00256	0.00256	CcSEcCtD
Cefuroxime—Pruritus—Vemurafenib—skin cancer	0.00255	0.00255	CcSEcCtD
Cefuroxime—Urethral disorder—Temozolomide—skin cancer	0.00254	0.00254	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Imiquimod—skin cancer	0.00251	0.00251	CcSEcCtD
Cefuroxime—Sinusitis—Fluorouracil—skin cancer	0.0025	0.0025	CcSEcCtD
Cefuroxime—Erythema—Dactinomycin—skin cancer	0.0025	0.0025	CcSEcCtD
Cefuroxime—Agranulocytosis—Fluorouracil—skin cancer	0.00248	0.00248	CcSEcCtD
Cefuroxime—Diarrhoea—Vemurafenib—skin cancer	0.00247	0.00247	CcSEcCtD
Cefuroxime—Erythema multiforme—Temozolomide—skin cancer	0.00245	0.00245	CcSEcCtD
Cefuroxime—Urticaria—Imiquimod—skin cancer	0.00244	0.00244	CcSEcCtD
Cefuroxime—Abdominal pain—Imiquimod—skin cancer	0.00243	0.00243	CcSEcCtD
Cefuroxime—Body temperature increased—Imiquimod—skin cancer	0.00243	0.00243	CcSEcCtD
Cefuroxime—Haemoglobin—Fluorouracil—skin cancer	0.0024	0.0024	CcSEcCtD
Cefuroxime—Leukopenia—Bleomycin—skin cancer	0.00239	0.00239	CcSEcCtD
Cefuroxime—Haemorrhage—Fluorouracil—skin cancer	0.00239	0.00239	CcSEcCtD
Cefuroxime—Dizziness—Vemurafenib—skin cancer	0.00238	0.00238	CcSEcCtD
Cefuroxime—Angiopathy—Temozolomide—skin cancer	0.00235	0.00235	CcSEcCtD
Cefuroxime—Immune system disorder—Temozolomide—skin cancer	0.00234	0.00234	CcSEcCtD
Cefuroxime—Cough—Bleomycin—skin cancer	0.00233	0.00233	CcSEcCtD
Cefuroxime—Chills—Temozolomide—skin cancer	0.00233	0.00233	CcSEcCtD
Cefuroxime—Vomiting—Vemurafenib—skin cancer	0.00229	0.00229	CcSEcCtD
Cefuroxime—Chest pain—Bleomycin—skin cancer	0.00228	0.00228	CcSEcCtD
Cefuroxime—Rash—Vemurafenib—skin cancer	0.00227	0.00227	CcSEcCtD
Cefuroxime—Dermatitis—Vemurafenib—skin cancer	0.00227	0.00227	CcSEcCtD
Cefuroxime—Hypersensitivity—Imiquimod—skin cancer	0.00226	0.00226	CcSEcCtD
Cefuroxime—Headache—Vemurafenib—skin cancer	0.00226	0.00226	CcSEcCtD
Cefuroxime—Erythema—Temozolomide—skin cancer	0.00226	0.00226	CcSEcCtD
Cefuroxime—Cramp muscle—Docetaxel—skin cancer	0.00224	0.00224	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00224	0.00224	CcSEcCtD
Cefuroxime—Leukopenia—Dactinomycin—skin cancer	0.00223	0.00223	CcSEcCtD
Cefuroxime—Anaphylactic shock—Bleomycin—skin cancer	0.00218	0.00218	CcSEcCtD
Cefuroxime—Pruritus—Imiquimod—skin cancer	0.00217	0.00217	CcSEcCtD
Cefuroxime—Nausea—Vemurafenib—skin cancer	0.00214	0.00214	CcSEcCtD
Cefuroxime—Thrombocytopenia—Bleomycin—skin cancer	0.00214	0.00214	CcSEcCtD
Cefuroxime—Diarrhoea—Imiquimod—skin cancer	0.0021	0.0021	CcSEcCtD
Cefuroxime—Anorexia—Bleomycin—skin cancer	0.00208	0.00208	CcSEcCtD
Cefuroxime—Erythema—Fluorouracil—skin cancer	0.00208	0.00208	CcSEcCtD
Cefuroxime—Agitation—Temozolomide—skin cancer	0.00207	0.00207	CcSEcCtD
Cefuroxime—Angioedema—Temozolomide—skin cancer	0.00206	0.00206	CcSEcCtD
Cefuroxime—Pancytopenia—Docetaxel—skin cancer	0.00205	0.00205	CcSEcCtD
Cefuroxime—Dizziness—Imiquimod—skin cancer	0.00203	0.00203	CcSEcCtD
Cefuroxime—Leukopenia—Temozolomide—skin cancer	0.00202	0.00202	CcSEcCtD
Cefuroxime—Neutropenia—Docetaxel—skin cancer	0.00201	0.00201	CcSEcCtD
Cefuroxime—Palpitations—Temozolomide—skin cancer	0.00199	0.00199	CcSEcCtD
Cefuroxime—Thrombocytopenia—Dactinomycin—skin cancer	0.00199	0.00199	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00199	0.00199	CcSEcCtD
Cefuroxime—Cough—Temozolomide—skin cancer	0.00197	0.00197	CcSEcCtD
Cefuroxime—Convulsion—Temozolomide—skin cancer	0.00196	0.00196	CcSEcCtD
Cefuroxime—Vomiting—Imiquimod—skin cancer	0.00195	0.00195	CcSEcCtD
Cefuroxime—Dyspnoea—Bleomycin—skin cancer	0.00195	0.00195	CcSEcCtD
Cefuroxime—Anorexia—Dactinomycin—skin cancer	0.00194	0.00194	CcSEcCtD
Cefuroxime—Rash—Imiquimod—skin cancer	0.00194	0.00194	CcSEcCtD
Cefuroxime—Dermatitis—Imiquimod—skin cancer	0.00194	0.00194	CcSEcCtD
Cefuroxime—Headache—Imiquimod—skin cancer	0.00193	0.00193	CcSEcCtD
Cefuroxime—Arthralgia—Temozolomide—skin cancer	0.00192	0.00192	CcSEcCtD
Cefuroxime—Infestation NOS—Docetaxel—skin cancer	0.00192	0.00192	CcSEcCtD
Cefuroxime—Infestation—Docetaxel—skin cancer	0.00192	0.00192	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00191	0.00191	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.0019	0.0019	CcSEcCtD
Cefuroxime—Decreased appetite—Bleomycin—skin cancer	0.0019	0.0019	CcSEcCtD
Cefuroxime—Renal failure—Docetaxel—skin cancer	0.00189	0.00189	CcSEcCtD
Cefuroxime—Stomatitis—Docetaxel—skin cancer	0.00187	0.00187	CcSEcCtD
Cefuroxime—Jaundice—Docetaxel—skin cancer	0.00187	0.00187	CcSEcCtD
Cefuroxime—Pain—Bleomycin—skin cancer	0.00187	0.00187	CcSEcCtD
Cefuroxime—Leukopenia—Fluorouracil—skin cancer	0.00186	0.00186	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00186	0.00186	CcSEcCtD
Cefuroxime—Anaphylactic shock—Temozolomide—skin cancer	0.00184	0.00184	CcSEcCtD
Cefuroxime—Nausea—Imiquimod—skin cancer	0.00183	0.00183	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Docetaxel—skin cancer	0.00182	0.00182	CcSEcCtD
Cefuroxime—Thrombocytopenia—Temozolomide—skin cancer	0.0018	0.0018	CcSEcCtD
Cefuroxime—Convulsion—Fluorouracil—skin cancer	0.0018	0.0018	CcSEcCtD
Cefuroxime—Agranulocytosis—Docetaxel—skin cancer	0.00179	0.00179	CcSEcCtD
Cefuroxime—Skin disorder—Temozolomide—skin cancer	0.00179	0.00179	CcSEcCtD
Cefuroxime—Hyperhidrosis—Temozolomide—skin cancer	0.00178	0.00178	CcSEcCtD
Cefuroxime—Chest pain—Fluorouracil—skin cancer	0.00177	0.00177	CcSEcCtD
Cefuroxime—Decreased appetite—Dactinomycin—skin cancer	0.00177	0.00177	CcSEcCtD
Cefuroxime—Anorexia—Temozolomide—skin cancer	0.00176	0.00176	CcSEcCtD
Cefuroxime—Pain—Dactinomycin—skin cancer	0.00174	0.00174	CcSEcCtD
Cefuroxime—Urticaria—Bleomycin—skin cancer	0.00173	0.00173	CcSEcCtD
Cefuroxime—Haemoglobin—Docetaxel—skin cancer	0.00173	0.00173	CcSEcCtD
Cefuroxime—Body temperature increased—Bleomycin—skin cancer	0.00173	0.00173	CcSEcCtD
Cefuroxime—Hepatitis—Docetaxel—skin cancer	0.00172	0.00172	CcSEcCtD
Cefuroxime—Haemorrhage—Docetaxel—skin cancer	0.00172	0.00172	CcSEcCtD
Cefuroxime—Urinary tract disorder—Docetaxel—skin cancer	0.0017	0.0017	CcSEcCtD
Cefuroxime—Anaphylactic shock—Fluorouracil—skin cancer	0.0017	0.0017	CcSEcCtD
Cefuroxime—Urethral disorder—Docetaxel—skin cancer	0.00169	0.00169	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00168	0.00168	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Dactinomycin—skin cancer	0.00167	0.00167	CcSEcCtD
Cefuroxime—Thrombocytopenia—Fluorouracil—skin cancer	0.00166	0.00166	CcSEcCtD
Cefuroxime—Tachycardia—Fluorouracil—skin cancer	0.00166	0.00166	CcSEcCtD
Cefuroxime—Dyspnoea—Temozolomide—skin cancer	0.00164	0.00164	CcSEcCtD
Cefuroxime—Somnolence—Temozolomide—skin cancer	0.00164	0.00164	CcSEcCtD
Cefuroxime—Erythema multiforme—Docetaxel—skin cancer	0.00163	0.00163	CcSEcCtD
Cefuroxime—Dyspepsia—Temozolomide—skin cancer	0.00162	0.00162	CcSEcCtD
Cefuroxime—Anorexia—Fluorouracil—skin cancer	0.00162	0.00162	CcSEcCtD
Cefuroxime—Body temperature increased—Dactinomycin—skin cancer	0.00161	0.00161	CcSEcCtD
Cefuroxime—Abdominal pain—Dactinomycin—skin cancer	0.00161	0.00161	CcSEcCtD
Cefuroxime—Hypersensitivity—Bleomycin—skin cancer	0.00161	0.00161	CcSEcCtD
Cefuroxime—Decreased appetite—Temozolomide—skin cancer	0.0016	0.0016	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Temozolomide—skin cancer	0.00159	0.00159	CcSEcCtD
Cefuroxime—Pain—Temozolomide—skin cancer	0.00158	0.00158	CcSEcCtD
Cefuroxime—Angiopathy—Docetaxel—skin cancer	0.00156	0.00156	CcSEcCtD
Cefuroxime—Immune system disorder—Docetaxel—skin cancer	0.00156	0.00156	CcSEcCtD
Cefuroxime—Chills—Docetaxel—skin cancer	0.00155	0.00155	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00155	0.00155	CcSEcCtD
Cefuroxime—Pruritus—Bleomycin—skin cancer	0.00154	0.00154	CcSEcCtD
Cefuroxime—Dyspnoea—Fluorouracil—skin cancer	0.00151	0.00151	CcSEcCtD
Cefuroxime—Somnolence—Fluorouracil—skin cancer	0.00151	0.00151	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Temozolomide—skin cancer	0.00151	0.00151	CcSEcCtD
Cefuroxime—Erythema—Docetaxel—skin cancer	0.0015	0.0015	CcSEcCtD
Cefuroxime—Hypersensitivity—Dactinomycin—skin cancer	0.0015	0.0015	CcSEcCtD
Cefuroxime—Dyspepsia—Fluorouracil—skin cancer	0.00149	0.00149	CcSEcCtD
Cefuroxime—Decreased appetite—Fluorouracil—skin cancer	0.00148	0.00148	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00147	0.00147	CcSEcCtD
Cefuroxime—Urticaria—Temozolomide—skin cancer	0.00146	0.00146	CcSEcCtD
Cefuroxime—Abdominal pain—Temozolomide—skin cancer	0.00146	0.00146	CcSEcCtD
Cefuroxime—Body temperature increased—Temozolomide—skin cancer	0.00146	0.00146	CcSEcCtD
Cefuroxime—Pain—Fluorouracil—skin cancer	0.00145	0.00145	CcSEcCtD
Cefuroxime—Muscle spasms—Docetaxel—skin cancer	0.00144	0.00144	CcSEcCtD
Cefuroxime—Diarrhoea—Dactinomycin—skin cancer	0.00139	0.00139	CcSEcCtD
Cefuroxime—Vomiting—Bleomycin—skin cancer	0.00139	0.00139	CcSEcCtD
Cefuroxime—Rash—Bleomycin—skin cancer	0.00138	0.00138	CcSEcCtD
Cefuroxime—Dermatitis—Bleomycin—skin cancer	0.00138	0.00138	CcSEcCtD
Cefuroxime—Hypersensitivity—Temozolomide—skin cancer	0.00136	0.00136	CcSEcCtD
Cefuroxime—Urticaria—Fluorouracil—skin cancer	0.00135	0.00135	CcSEcCtD
Cefuroxime—Leukopenia—Docetaxel—skin cancer	0.00134	0.00134	CcSEcCtD
Cefuroxime—Body temperature increased—Fluorouracil—skin cancer	0.00134	0.00134	CcSEcCtD
Cefuroxime—Palpitations—Docetaxel—skin cancer	0.00133	0.00133	CcSEcCtD
Cefuroxime—Cough—Docetaxel—skin cancer	0.00131	0.00131	CcSEcCtD
Cefuroxime—Pruritus—Temozolomide—skin cancer	0.0013	0.0013	CcSEcCtD
Cefuroxime—Convulsion—Docetaxel—skin cancer	0.0013	0.0013	CcSEcCtD
Cefuroxime—Nausea—Bleomycin—skin cancer	0.0013	0.0013	CcSEcCtD
Cefuroxime—Vomiting—Dactinomycin—skin cancer	0.00129	0.00129	CcSEcCtD
Cefuroxime—Rash—Dactinomycin—skin cancer	0.00128	0.00128	CcSEcCtD
Cefuroxime—Arthralgia—Docetaxel—skin cancer	0.00128	0.00128	CcSEcCtD
Cefuroxime—Chest pain—Docetaxel—skin cancer	0.00128	0.00128	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00127	0.00127	CcSEcCtD
Cefuroxime—Diarrhoea—Temozolomide—skin cancer	0.00126	0.00126	CcSEcCtD
Cefuroxime—Hypersensitivity—Fluorouracil—skin cancer	0.00125	0.00125	CcSEcCtD
Cefuroxime—Anaphylactic shock—Docetaxel—skin cancer	0.00122	0.00122	CcSEcCtD
Cefuroxime—Dizziness—Temozolomide—skin cancer	0.00122	0.00122	CcSEcCtD
Cefuroxime—Nausea—Dactinomycin—skin cancer	0.00121	0.00121	CcSEcCtD
Cefuroxime—Pruritus—Fluorouracil—skin cancer	0.0012	0.0012	CcSEcCtD
Cefuroxime—Thrombocytopenia—Docetaxel—skin cancer	0.0012	0.0012	CcSEcCtD
Cefuroxime—Tachycardia—Docetaxel—skin cancer	0.0012	0.0012	CcSEcCtD
Cefuroxime—Skin disorder—Docetaxel—skin cancer	0.00119	0.00119	CcSEcCtD
Cefuroxime—Vomiting—Temozolomide—skin cancer	0.00117	0.00117	CcSEcCtD
Cefuroxime—Anorexia—Docetaxel—skin cancer	0.00117	0.00117	CcSEcCtD
Cefuroxime—Rash—Temozolomide—skin cancer	0.00116	0.00116	CcSEcCtD
Cefuroxime—Diarrhoea—Fluorouracil—skin cancer	0.00116	0.00116	CcSEcCtD
Cefuroxime—Dermatitis—Temozolomide—skin cancer	0.00116	0.00116	CcSEcCtD
Cefuroxime—Headache—Temozolomide—skin cancer	0.00115	0.00115	CcSEcCtD
Cefuroxime—Dizziness—Fluorouracil—skin cancer	0.00112	0.00112	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00112	0.00112	CcSEcCtD
Cefuroxime—Nausea—Temozolomide—skin cancer	0.00109	0.00109	CcSEcCtD
Cefuroxime—Dyspnoea—Docetaxel—skin cancer	0.00109	0.00109	CcSEcCtD
Cefuroxime—Somnolence—Docetaxel—skin cancer	0.00109	0.00109	CcSEcCtD
Cefuroxime—Vomiting—Fluorouracil—skin cancer	0.00108	0.00108	CcSEcCtD
Cefuroxime—Dyspepsia—Docetaxel—skin cancer	0.00108	0.00108	CcSEcCtD
Cefuroxime—Rash—Fluorouracil—skin cancer	0.00107	0.00107	CcSEcCtD
Cefuroxime—Dermatitis—Fluorouracil—skin cancer	0.00107	0.00107	CcSEcCtD
Cefuroxime—Decreased appetite—Docetaxel—skin cancer	0.00106	0.00106	CcSEcCtD
Cefuroxime—Headache—Fluorouracil—skin cancer	0.00106	0.00106	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Docetaxel—skin cancer	0.00106	0.00106	CcSEcCtD
Cefuroxime—Pain—Docetaxel—skin cancer	0.00105	0.00105	CcSEcCtD
Cefuroxime—Nausea—Fluorouracil—skin cancer	0.00101	0.00101	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Docetaxel—skin cancer	0.001	0.001	CcSEcCtD
Cefuroxime—Body temperature increased—Docetaxel—skin cancer	0.000968	0.000968	CcSEcCtD
Cefuroxime—Abdominal pain—Docetaxel—skin cancer	0.000968	0.000968	CcSEcCtD
Cefuroxime—Hypersensitivity—Docetaxel—skin cancer	0.000903	0.000903	CcSEcCtD
Cefuroxime—Pruritus—Docetaxel—skin cancer	0.000867	0.000867	CcSEcCtD
Cefuroxime—Diarrhoea—Docetaxel—skin cancer	0.000838	0.000838	CcSEcCtD
Cefuroxime—Dizziness—Docetaxel—skin cancer	0.00081	0.00081	CcSEcCtD
Cefuroxime—Vomiting—Docetaxel—skin cancer	0.000779	0.000779	CcSEcCtD
Cefuroxime—Rash—Docetaxel—skin cancer	0.000772	0.000772	CcSEcCtD
Cefuroxime—Dermatitis—Docetaxel—skin cancer	0.000772	0.000772	CcSEcCtD
Cefuroxime—Headache—Docetaxel—skin cancer	0.000767	0.000767	CcSEcCtD
Cefuroxime—Nausea—Docetaxel—skin cancer	0.000728	0.000728	CcSEcCtD
